my account  log out
 

Magic™ TCR Repertoire Analysis for Minimal Residual Disease Quantification

Create: 03/26/2019
Expired Date:never
Category: Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:Creative Biolabs has applied our advanced Magic™ TCR repertoire analysis platform to MRD quantification for highly accurate and reproducible results. MRD is the name given to small numbers of leukemic cells or other cancer cells that remain in the patient during treatment or after treatment when the patient is in remission. It is the major cause of relapse in cancer and leukemia. https://www.creative-biolabs.com/tcr-repertoire-analysis-for-minimal-residual-disease-quantification.html
City:Shirley[US] 
Location:
 
Feb 01 2023 VBS++ (with Ca and Mg) Buffer232
Feb 01 2023 GVBE Buffer232
Feb 01 2023 GVB++ (with Ca and Mg) Buffer239
Feb 01 2023 Hemolysin (Rabbit Anti-Sheep Cell Hemolysin)227
Aug 30 2019Anti-HSV-2 gH Antibody420
Aug 30 2019Anti-L. major LPG Antibody501
Aug 30 2019Anti-DENV-1 Antibody410
Aug 30 2019Anti-BPV-1 L1 Antibody427
Aug 30 2019Anti-H3N2 HA Antibody408
Aug 30 2019Anti-EIAV env Antibody435

return back

Copyright © toextrade Inc. All rights reserved. Contact us